References
- Beschorner, W. E., Namnoum, J. D., Hess, A. D., Shinn, C. A., Santos, G. W. 1987. Cyclosporin A and the thymus. Immunopathology. Am. J. Pathol. 126:487–496.
- Brode, S., Cooke, A. 2008. Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide. Crit. Rev. Immunol. 28:109–126.
- Calne, R. Y. 1979. Pharmacological immunosuppression in clinical organ grafting. Observations on four agents: Cyclosporin A, Asta 5122 (cytimun), lambda carrageenan and promethazine hydrochloride. Clin. Exp. Immunol. 35:1–9.
- Finco-Kent, D., Kawabata, T. T. 2005. Development and validation of a canine T-cell-dependent antibody response model for immunotoxicity evaluation. J. Immunotoxicol. 2:197–201.
- Haggerty, H. G. 2007. Immunotoxicity testing in non-rodent species. J. Immunotoxicol. 4:165–169.
- ICH. 2005. ICH Guideline S8 on Immunotoxicity Studies for Human Pharmaceuticals. Available online at: http://www.ich.org/products/guidelines/safety/article/safety-guidelines.html.
- Jones, R. D., Offutt, D. M., Longmoor, B. A. 2000. Capture ELISA and flow cytometry methods for toxicologic assessment following immunization and cyclophosphamide challenges in beagles. Toxicol. Lett. 115:33–44.
- Lebrec, H., O'Lone, R., Freebern, W., Komocsar, W., Moore, P. 2012. Survey: Immune function and immunotoxicity assessment in dogs. J. Immunotoxicol. 9:1–14.
- Medleau, L., Dawe, D. L., Calvert, C. A. 1983. Immunosuppressive effects of cyclophosphamide, vincristine, and L-asparaginase in dogs. Am. J. Vet. Res. 44:176–180.
- Putnam, C. W., Halgrimson, C. G., Groth, C. G., Kashiwagi, N., Porter, K. A., Starzl, T. E. 1975. Immunosuppression with cyclophosphamide in the dog. Clin. Exp. Immunol. 22:323–329.
- Shand, F. L. 1979. The immunopharmacology of cyclophosphamide. Int. J. Immunopharmacol. 1:165–171.
- Takaori, K., Nio, Y., Inoue, K., Tun, T., Fukumoto, M., Hashida, T., Yasuhara, M., Hori, R., Tobe, T. 1992. A comparative study on immunosuppressive effects of cyclosporin A and FK 506 on peripheral blood lymphocytes in dogs. Biotherapy 4:129–137.
- Thiem, P. A., Halper, L. K., Bloom, J. C. 1988. Techniques for assessing canine mononuclear phagocyte function as part of an immunotoxicologic evaluation. Int. J. Immunopharmacol. 10:765–771.
- White, K. L. Jr., Sheth, C. M., Peachee, V. L. 2007. Comparison of primary immune responses to SRBC and KLH in rodents. J. Immunotoxicol. 4:153–158.